COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,726 Articles (22,502 medRxiv, 8,224 bioRxiv)

Most recent first Previous |  Page 1496: Articles 14951-14960  | Next

COVID-19 cases from the first local outbreak of SARS-CoV-2 B.1.1.7 variant in China presented more serious clinical features: a prospective, comparative cohort study
Song, Y., Ge, Z., Cui, S., Tian, D., Wan, G., Zhu, S., Wang, X., Wang, Y., Zhao, X., Xiang, P., Xu, Y., Zhang, T., Liu, L., Liu, G., Wang, Y., Tan, J., Zhang, W., Xu, W., Chen, Z.
10.1101/2021.05.04.21256655 — Posted: 2021-05-08
Identification of risk and protective human leukocyte antigens in COVID-19 using genotyping and structural modeling
Shen, Y., Ostrov, D., Rananaware, S., Jain, P. K., Nguyen, C.
10.1101/2021.05.04.21256636 — Posted: 2021-05-08
Vaccination strategies when vaccines are scarce: On conflicts between reducing the burden and avoiding the evolution of escape mutants
Geoffroy, F., Traulsen, A., Uecker, H.
10.1101/2021.05.04.21256623 — Posted: 2021-05-08
The evidence on transmission dynamics of COVID-19 from pre and asymptomatic cases: protocol for a systematic review
Jefferson, T., Pluddemann, A., Spencer, E., Brassey, J., Rosca, C., ONAKPOYA, I., Heneghan, C., Evans, D., Conly, J.
10.1101/2021.05.06.21256615 — Posted: 2021-05-08 Discussion: Onsite
Effect of storage conditions on SARS-CoV-2 RNA quantification in wastewater solids
Simpson, A., Topol, A., White, B., Wolfe, M., Wigginton, K., Boehm, A. B.
10.1101/2021.05.04.21256611 — Posted: 2021-05-08
Meta-Analysis of Risk of Vaccine-Induced Immune Thrombotic Thrombocytopenia Following ChAdOx1-S Recombinant Vaccine
Chan, B. T. B., Bobos, P., Odutayo, A., Pai, M.
10.1101/2021.05.04.21256613 — Posted: 2021-05-08 Discussion: Onsite
Assessing COVID-19 Pandemic Risk Perception and Response Preparedness in Veterinary and Animal Care Workers
Dalton, K. R., Guyer, K. M., Schiaffino, F., Ferradas, C., Ferradas, J. R., Beasley, E. A., Meza, K., Laughlin, P., Agnew, J., Barnett, D. J., Nuzzo, J. B., Davis, M. F.
10.1101/2021.05.04.21256626 — Posted: 2021-05-08
Higher case fatality rate among obstetric patients with COVID-19 in the second year of pandemic in Brazil: do new genetic variants play a role?
Takemoto, M. L. S., Nakamura-Pereira, M., Menezes, M. d. O., Katz, L., Knobel, R., Amorim, M. M. R., Andreucci, C. B.
10.1101/2021.05.06.21256651 — Posted: 2021-05-08
The COVID-19 pandemic storm in India
Nesteruk, I.
10.1101/2021.05.06.21256523 — Posted: 2021-05-08
Illness duration and symptom profile in a large cohort of symptomatic UK school-aged children tested for SARS-CoV-2
Molteni, E., Sudre, C. H., Canas, L. S., Bhopal, S. S., Hughes, R. C., Antonelli, M. S., Murray, B., Klaser, K., Kerfoot, E., Chen, L., Deng, J., Hu, C., Selvachandran, S., Read, K., Pujol, J. C., Hammers, A., Spector, T., Ourselin, S., Steves, C. J., Modat, M., Absoud, M., Duncan, E. L.
10.1101/2021.05.05.21256649 — Posted: 2021-05-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).